Inmune Stock Probability of Future Stock Price Finishing Over 9.56

INMB
 Stock
  

USD 9.41  0.29  3.18%   

Inmune Bio's future price is the expected price of Inmune Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Inmune Bio performance during a given time horizon utilizing its historical volatility. Inmune Bio Price to Book Value is projected to increase slightly based on the last few years of reporting. The past year's Price to Book Value was at 2.27. The current year Price to Sales Ratio is expected to grow to 932.93, whereas Price to Earnings Ratio are forecasted to decline to (5.86) .
  
Inmune Bio's implied volatility is one of the determining factors in the pricing options written on Inmune Bio. Implied volatility approximates the future value of Inmune Bio based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Inmune Bio over a specific time period. For example, 2022-08-19 CALL at $10.0 is a CALL option contract on Inmune Bio's common stock with a strick price of 10.0 expiring on 2022-08-19. The contract was last traded on 2022-08-05 at 12:25:15 for $0.75 and, as of today, has 7 days remaining before the expiration. The option is currently trading at a bid price of $0.1, and an ask price of $0.7. The implied volatility as of the 12th of August 2022 is 324.9897. View All Inmune options

Closest to current price Inmune long CALL Option Payoff at Expiration

Please see Inmune Bio Backtesting, Inmune Bio Valuation, Inmune Bio Correlation, Inmune Bio Hype Analysis, Inmune Bio Volatility, Inmune Bio History as well as Inmune Bio Performance. Please specify Inmune Bio time horizon, a valid symbol (red box) and a target price (blue box) you would like Inmune Bio odds to be computed.

Inmune Bio Target Price Odds to finish over 9.56

The tendency of Inmune Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 9.56  or more in 90 days
 9.41 90 days 9.56 
about 18.04
Based on a normal probability distribution, the odds of Inmune Bio to move over $ 9.56  or more in 90 days from now is about 18.04 (This Inmune Bio probability density function shows the probability of Inmune Stock to fall within a particular range of prices over 90 days) . Probability of Inmune Bio price to stay between its current price of $ 9.41  and $ 9.56  at the end of the 90-day period is roughly 2.97 .
Given the investment horizon of 90 days Inmune Bio has a beta of -0.36. This usually indicates as returns on benchmark increase, returns on holding Inmune Bio are expected to decrease at a much lower rate. During the bear market, however, Inmune Bio is likely to outperform the market. Additionally The company has an alpha of 0.5808, implying that it can generate a 0.58 percent excess return over DOW after adjusting for the inherited market risk (beta).
   Inmune Bio Price Density   
       Price  

Predictive Modules for Inmune Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inmune Bio. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inmune Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inmune Bio in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
3.909.4915.08
Details
Intrinsic
Valuation
LowReal ValueHigh
8.4715.7821.37
Details
Naive
Forecast
LowNext ValueHigh
4.399.9915.58
Details
2 Analysts
Consensus
LowTarget PriceHigh
32.0037.0042.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inmune Bio. Your research has to be compared to or analyzed against Inmune Bio's peers to derive any actionable benefits. When done correctly, Inmune Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inmune Bio.

Inmune Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Inmune Bio is not an exception. The market had few large corrections towards the Inmune Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Inmune Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Inmune Bio within the framework of very fundamental risk indicators.
α
Alpha over DOW
0.58
β
Beta against DOW-0.36
σ
Overall volatility
1.39
Ir
Information ratio 0.09

Inmune Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Inmune Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Inmune Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Inmune Bio is way too risky over 90 days horizon
Inmune Bio appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 340 K. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 181 K.
Inmune Bio currently holds about 66.73 M in cash with (32.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72.
Inmune Bio has a frail financial position based on the latest SEC disclosures
Roughly 35.0% of the company shares are held by company insiders
Latest headline from EPS REPORTED: EPS Reported

Inmune Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Inmune Stock often depends not only on the future outlook of the current and potential Inmune Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inmune Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out5.62%
Short Percent Of Float8.64%
Float Shares11.66M
Shares Short Prior Month1.1M
Average Daily Volume Last 10 Day59.72k
Average Daily Volume In Three Month110.75k
Date Short Interest15th of July 2022

Inmune Bio Technical Analysis

Inmune Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Inmune Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Inmune Bio. In general, you should focus on analyzing Inmune Stock price patterns and their correlations with different microeconomic environments and drivers.

Inmune Bio Predictive Forecast Models

Inmune Bio time-series forecasting models is one of many Inmune Bio's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inmune Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Inmune Bio

Checking the ongoing alerts about Inmune Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Inmune Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Inmune Bio Alerts

Inmune Bio Alerts and Suggestions

Inmune Bio is way too risky over 90 days horizon
Inmune Bio appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 340 K. Net Loss for the year was (32.69 M) with profit before overhead, payroll, taxes, and interest of 181 K.
Inmune Bio currently holds about 66.73 M in cash with (32.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72.
Inmune Bio has a frail financial position based on the latest SEC disclosures
Roughly 35.0% of the company shares are held by company insiders
Latest headline from EPS REPORTED: EPS Reported
Please see Inmune Bio Backtesting, Inmune Bio Valuation, Inmune Bio Correlation, Inmune Bio Hype Analysis, Inmune Bio Volatility, Inmune Bio History as well as Inmune Bio Performance. Note that the Inmune Bio information on this page should be used as a complementary analysis to other Inmune Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Inmune Stock analysis

When running Inmune Bio price analysis, check to measure Inmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmune Bio is operating at the current time. Most of Inmune Bio's value examination focuses on studying past and present price action to predict the probability of Inmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmune Bio's price. Additionally, you may evaluate how the addition of Inmune Bio to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Is Inmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmune Bio. If investors know Inmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
167.4 M
Quarterly Revenue Growth YOY
39.75
Return On Assets
-0.26
Return On Equity
-0.58
The market value of Inmune Bio is measured differently than its book value, which is the value of Inmune that is recorded on the company's balance sheet. Investors also form their own opinion of Inmune Bio's value that differs from its market value or its book value, called intrinsic value, which is Inmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmune Bio's market value can be influenced by many factors that don't directly affect Inmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Inmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.